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AbstrACt
Introduction Low-income and middle-income countries 
(LMICs) are crucial in the global response to antimicrobial 
resistance (AMR), but diverse health systems, healthcare 
practices and cultural conceptions of medicine can 
complicate global education and awareness-raising 
campaigns. Social research can help understand LMIC 
contexts but remains under-represented in AMR research.
Objective To (1) Describe antibiotic-related knowledge, 
attitudes and practices of the general population in two 
LMICs. (2) Assess the role of antibiotic-related knowledge 
and attitudes on antibiotic access from different types of 
healthcare providers.
Design Observational study: cross-sectional rural health 
behaviour survey, representative of the population level.
setting General rural population in Chiang Rai (Thailand) 
and Salavan (Lao PDR), surveyed between November 2017 
and May 2018.
Participants 2141 adult members (≥18 years) of the 
general rural population, representing 712 000 villagers.
Outcome measures Antibiotic-related knowledge, 
attitudes and practices across sites and healthcare access 
channels.
Findings Villagers were aware of antibiotics (Chiang Rai: 
95.7%; Salavan: 86.4%; p<0.001) and drug resistance 
(Chiang Rai: 74.8%; Salavan: 62.5%; p<0.001), but the 
usage of technical concepts for antibiotics was dwarfed 
by local expressions like ‘anti-inflammatory medicine’ in 
Chiang Rai (87.6%; 95% CI 84.9% to 90.0%) and ‘ampi’ 
in Salavan (75.6%; 95% CI 71.4% to 79.4%). Multivariate 
linear regression suggested that attitudes against over-
the-counter antibiotics were linked to 0.12 additional 
antibiotic use episodes from public healthcare providers 
in Chiang Rai (95% CI 0.01 to 0.23) and 0.53 in Salavan 
(95% CI 0.16 to 0.90).
Conclusions Locally specific conceptions and 
counterintuitive practices around antimicrobials can 
complicate AMR communication efforts and entail 
unforeseen consequences. Overcoming ‘knowledge 
deficits’ alone will therefore be insufficient for global AMR 
behaviour change. We call for an expansion of behavioural 
AMR strategies towards ‘AMR-sensitive interventions’ that 
address context-specific upstream drivers of antimicrobial 
use (eg, unemployment insurance) and complement 
education and awareness campaigns.
trial registration number  Clinicaltrials. gov identifier 
NCT03241316.
IntrODuCtIOn
Antimicrobial resistance (AMR) threatens 
modern medicine by rendering antimicrobial 
drugs ineffective. Multifaceted global strate-
gies target human, animal and plant health 
alongside the environment, food production 
strength and limitations of this study
 ► Provincial-level representative survey using a three-
stage stratified cluster random sampling design.
 ► Survey based on preceding qualitative research on 
antibiotic use in South-East Asia.
 ► Inclusion of the general population enables insights 
into formal and informal healthcare utilisation.
 ► Cross-sectional analysis of rural health behaviours 
excludes seasonal change and urban settings.
 ► Two-month recall period enabled greater inclusion 
but may bias responses towards better educated 
population groups.
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and safety to respond to this ‘superbug crisis’.1 In human 
health, supply side responses include incentives to stim-
ulate drug research and development; action on the 
demand side intends to limit and target antimicrobial 
use, for instance, through new diagnostic technologies, 
public health interventions to improve vaccine coverage 
and hygiene, and other antimicrobial stewardship activi-
ties like restricted dispensing of antibiotics and prescriber 
feedback.2–4 As an interdisciplinary field, the social dimen-
sions of the problem are being recognised in global AMR 
policy, which are typically addressed via education and 
awareness-raising activities aimed at governmental staff, 
healthcare workers and the general public.2
Low-income and middle-income countries (LMICs) 
play an important role in the global response to AMR. 
However, diverse health systems, healthcare practices and 
conceptions related to the use of antimicrobials require 
social research to understand local contexts and the 
complexity of human behaviour in LMIC settings. For 
example, with a focus on the health behaviour of the 
general public, the anthropological literature suggests 
that social factors like precarity and discrimination can 
influence medicine use independently of awareness;5 
psychology and behavioural economics indicate that 
health decision-making processes interact with the social 
environment and contextual change to create adverse 
behavioural biases;6 7 and communication studies research 
points at interferences between awareness campaigns and 
local contexts that can entail unforeseen consequences 
like politicisation, stigmatisation or accidentally encour-
aging the behaviours they try to discourage.8 9 Such exam-
ples underline the possible contribution of the social 
sciences to AMR, but they remain persistently under-rep-
resented with less than 2% of all AMR-related publica-
tions (see online supplementary file 1 - figure A1 for a 
time trend).10 This under-representation is problematic 
for at least three reasons:
 ► We currently have an insufficient social science knowl-
edge base for behavioural interventions in AMR—a 
global health priority that has attracted more than 
£600 million of expenditure and future commitments 
for research and surveillance.11–13
 ► The recent withdrawal of large pharmaceutical compa-
nies from antimicrobial research and development14 
threatens the AMR supply side response, requiring yet 
more effective action on the demand side.
 ► More extensive social sciences work can yield 
novel social innovations as a benefit of disciplinary 
diversification.15
Using social research methods, the objectives of this 
paper were to (1) Describe antibiotic-related knowledge, 
attitudes and practices of the general population in two 
LMICs. (2) Assess the role of antibiotic-related knowledge 
and attitudes on antibiotic access from different types of 
healthcare providers. We report findings from a provin-
cial-level representative survey of rural health behaviours 
across 69 villages in northern Thailand and 65 villages 
in southern Lao PDR as part of the interdisciplinary 
‘Antibiotics and Activity Spaces’ project.16 (This paper 
contributes to the project’s research question, ‘What are 
the manifestations and determinants of problematic antibiotic 
use in patients’ healthcare-seeking pathways?’.16) We imple-
mented the study in South-East Asia, which is character-
ised as a region ‘at high risk of the emergence and spread 
of antibiotic resistance in humans’.17 18 With more than 
9% of global air passengers and more than 110 million 
international tourist arrivals in 2016,19 the potential of 
cross-border spread of drug-resistant microbes also gives 
AMR research in South-East Asia a global relevance—as 
the recent importation of multidrug-resistant Neisseria 
gonorrhoeae to the UK showed.20 Within South-East Asia, 
Thailand and Lao PDR lent themselves for a compara-
tive analysis because of their physical and cultural prox-
imity, and Chiang Rai (Thailand) and Salavan (Lao PDR) 
in particular had similar terrain and large and ethnically 
diverse rural populations. The main field site differences 
were Thailand’s more advanced economic and health 
system context and more established AMR action plan.21 
For example, Thailand maintains a national strategic 
plan on AMR (2017–2021),22 its public health expendi-
ture per capita in 2016 was nearly 10 times higher than 
Lao’s (US$496.2 vs US$50.1 in purchasing power parity), 
and Thailand had 2.3 nurses per 1000 people in 2015, 
compared with 1.0 per 1000 people in Lao PDR in 2014.19
MethODs
Multistage survey design
Our study design was a three-stage stratified cluster 
random survey (figure 1): Following the purposive selec-
tion of five districts per province, we selected a random 
sample of 30 primary sampling units (PSUs) per prov-
ince (six per district), stratified by distance to the nearest 
district headquarters. The second stage was the selection 
of an interval sample of 5% but at least 30 of all house-
holds in the PSU, which we approximated as residential 
structures on satellite maps.23 Participants were sampled 
in the third and final stage. This process involved the 
random selection of available household members (one 
for every five members). At each sampling stage, we substi-
tuted unavailable selections (1) With a stratified random 
replacement for the random PSU sample. (2) With the 
nearest available neighbour for the interval sample of 
households. (3) With a simple random replacement for 
the random household member sample (replacement 
numbers indicated in figure 1). The cross-sectional data 
collection took place between November 2017 and May 
2018.
study population
Our study population was the general adult population of 
rural Chiang Rai and Salavan (522 000 in Chiang Rai and 
190 000 in Salavan as per census data), from whom we 
drew a representative sample of 1158 villagers in Chiang 
Rai and 983 in Salavan. We did not specifically sample 
patients, but we recorded any acute illness episode or 
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Figure 1 Survey sites and multistage sampling process (adapted from Wikimedia Commons [36]). Notes: Unavailable 
selections at each sampling stage were substituted with a random replacement for the random samples of PSUs and household 
members, and with the nearest available neighbour for the interval sample of households. One PSU could contain more than 
one administrative village; if the first-chosen village contained less than 600 houses, then adjacent villages would be included. 
PSU, primary sampling unit.
accident-related injury if one occurred within the last 
2 months of the interview, both for the respondents and 
any children under their supervision.
Patient and public involvement
This study did not sample patients but only adult members 
of the general public. The survey instrument was based 
on preceding qualitative research in South-East Asia,24 25 
in which patients, healthcare providers and healthy adults 
participated, but patients or members of the public were 
not directly involved in the design or conception of the 
study. This preceding research prompted the research 
interest in treatment-seeking behaviours and conceptions 
of medicine and illness among the broader rural popu-
lation in South-East Asia. We will disseminate our find-
ings through outreach to policy stakeholders and local 
development organisations, through public engagement 
activities like the World Antibiotic Awareness Week, and 
though our local network of collaborators in the field 
sites.
Data collection
Our survey instrument was a 45 min face-to-face question-
naire (see online supplementary file 2). It was adminis-
tered on tablets running the survey software SurveyCTO 
(Dobility, Cambridge, Massachusetts, USA) by locally 
recruited survey teams comprising seven enumerators 
and two survey supervisors per country, who received 
5 days of full-time classroom and field training. The 
original English questionnaire was co-developed with, 
and translated into Thai and Lao by, the local research 
team (we refrained from additional back-translation as 
the local language versions of the questionnaire were 
based on qualitative research material that we had previ-
ously used in the region, aided further by field pilots 
and cognitive interviewing), and local translators were 
recruited for the 228 instances where we encountered 
language barriers. The questionnaires were piloted in 
rural Chiang Rai and Salavan, with 50 cognitive inter-
views supporting the questionnaire development and 
revision as well as the contextualisation of the survey 
data (not reported here; interview guide in online 
supplementary file 3).26
The questionnaire covered basic demographic and 
socioeconomic information, antibiotic-related knowl-
edge and attitudes, and treatment-seeking behaviour 
during acute illnesses and accident-related injuries. 
When measuring people’s awareness of antibiotics, we 
could not simply ask villagers whether they knew what 
‘antibiotics’ are, considering that (1) A variety of local 
terms related to antibiotics existed. (2) People may be 
familiar with specific antibiotic brands but not aware of 
their antibiotic attributes. (3) The understanding of tech-
nical language was uncommon (see Results section for 
evidence on this point). We therefore asked respondents 
first if they recognised images of common antibiotics in 
the field site (three images on the survey tablet in Chiang 
Rai and a bag with seven local antibiotics in Salavan, 
considering the wider range of terms and medicines in 
circulation in the Lao site; see questionnaire in online 
supplementary file 2). In the 108/1974 (5.5%) cases 
where the respondents did not mention ‘antibiotics’, its 
colloquial equivalents, or the names of specific antibiotic 
types, we asked them if they had heard about ‘anti-in-
flammatory drugs’ (‘ยาแก้อักเสบ’ or ‘yah kae ak seb’) in 
Thai and ‘germ resisters’ (‘ຢາຕ້ານເຊື້ອ’ or ‘yah dtan 
suea’) in Lao as common local notions of ‘antibiotics’. We 
next asked about the purposes for which the respondent 
would use these antibiotics, which served as information 
alongside inputs from local pharmacists to triangulate in 
later parts of the questionnaire whether the respondent 
received antibiotics during an illness. However, 752/2986 
(25.2%) medicine use episodes could not be confirmed 
as either antibiotic or non-antibiotic (eg, ‘white powder’ 
or ‘green capsule‘). We included these uncertain cases as 
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‘potential’ antibiotic use episodes to capture behaviour 
more comprehensively.
Data analysis
In order to inform the current global health agenda 
on antibiotic education and awareness raising, we used 
descriptive statistical analysis and regression analysis to 
describe the patterns of knowledge and attitudes—and 
their role in determining antibiotic use—across the two 
field sites, using the variables described in online supple-
mentary file 1 - table A1. If the common policy narrative 
holds, then we would expect rural populations in Chiang 
Rai and Salavan to exhibit:
 ► Low degrees of antibiotic-related knowledge.
 ► Generally high levels of antibiotic consumption espe-
cially from informal sources (eg, unregistered shops 
selling antibiotics over the counter).
 ► Lower general antibiotic use and a higher share of 
supervised antibiotic use from formal healthcare 
providers among people whose attitudes correspond 
to awareness-raising messages for AMR (based on 
FAO/OIE/WHO material, see online supplementary 
file 1 - table A1).1
We stratified and compared the samples by field site 
(ie, province) to account for the systemic influence of the 
health system configuration on people’s health knowledge 
and behaviour. We estimated provincially representative 
patterns using poststratification weights based on census 
data (considering village size and district-specific age and 
gender composition) and adjusting the descriptive and 
regression analysis results for the multistage sampling 
design with the help of the svy suite of commands in 
Stata V.15 (StataCorp, College Station, Texas, USA). We 
separately analysed the full sample and the subset of 
respondents who reported a recent illness, whereby we 
tested differences in knowledge, attitudes and behav-
iours across provinces and across antibiotic access chan-
nels with Χ2 tests for binary and Wilcoxon rank-sum tests 
(two-sided) for non-normally distributed variables. We 
further carried out multivariate analysis of the determi-
nants of antibiotic use from public (public hospitals and 
primary care units), private (private hospitals, clinics and 
pharmacies) and informal sources (grocery stores selling 
medicine, traditional healers). The multivariate analysis 
used linear regression models adjusted by the complex 
survey design (sampling clusters and survey weights), 
which we compared across the two country samples, using 
the Chow test to ascertain systematic differences in the 
determinants of antibiotic use across the two field sites.27
Although the dependent variables were not normally 
distributed, the otherwise preferable functional form of 
Poisson regression did not converge in most cases owing 
to the relatively small sample sizes. However, where they 
did converge, the linear regressions yielded more conser-
vative estimates. Likewise, the linear regressions adjusted 
by the complex survey design yielded more conservative 
results than linear multilevel models that take the hier-
archical structure of the data into account. We therefore 
present the linear regression results in this article. For 
improved model fitness and to reduce the influence of 
outliers, we further substituted the duration of the illness 
with its log. To test for multicollinearity in the cross-sec-
tional survey data, we analysed the pairwise correlations 
between all independent variables stratified by field site, 
whereby the largest correlation coefficients in Chiang Rai 
were +0.59 (ethnicity/religion) and –0.50 (education/
age), and in Salavan +0.76 (ethnicity/religion) and +0.62 
(religion/wealth) (see online supplementary file 1 - table 
A3). The largest variance inflation factors (VIFs) were 
for the dummy variables of religion (VIF = 3.12 in the 
Salavan sample) and ethnicity (VIF = 2.01 in the Chiang 
Rai sample), the exclusion of which from the regression 
models did not produce meaningful differences in param-
eter estimates or significance levels of the other indepen-
dent variables. We therefore presented the full regression 
models to not omit independent variables selectively. We 
indicated significance levels below 0.1, 0.05 and 0.01 with 
*, ** and ***, respectively.
results
Representative statistical data of Chiang Rai and Salavan 
are presented in online supplementary appendix table 1. 
In terms of sociodemographic characteristics of the rural 
population in the two provinces, Chiang Rai villagers 
were older on average (p<0.001), tended to have received 
more formal education (p<0.001) and had higher asset 
wealth (p<0.001), while fewer Salavan villagers belonged 
to the local majority ethnicity (p=0.030).
Respondents’ recognition of antibiotics in Chiang 
Rai was significantly higher than in Salavan, but overall 
high in both sites (Chiang Rai: 95.7%; Salavan: 86.4%; 
p<0.001). Recognition of the phrase ‘drug resistance’ 
was high as well, whereby 74.8% recognised the term in 
Chiang Rai and 62.5% (p<0.001) recognised either of the 
two common variations in Salavan. Online supplementary 
appendix table 1 further indicates that antibiotic-related 
knowledge and attitudes aligned more closely with FAO/
OIE/WHO (Food and Agriculture Organization of the 
United Nations, World Organisation for Animal Health, 
World Health Organization) messages in Chiang Rai than 
in Salavan (p<0.001 for all four questions). Across the 
four questions, respondents in rural Chiang Rai had an 
average answer score of 1.8 as opposed to rural Salavan 
with 0.7 (p<0.001).
Figure 2, Panel A, demonstrates the ways in which 
people related to ‘antibiotics’. In Chiang Rai, respondents 
commonly referred to antibiotics as ‘anti-inflammatory 
drug’, representing 87.6% of all responses (‘ยาแก้อักเสบ’ 
or ‘yah kae ak seb’; a vernacular notion specific to antibi-
otics). (Actual anti-inflammatory medicine like ibuprofen 
would usually be referred to by its brand names.) Only 
7.2% used the official term for 'antibiotic’ (‘ยาปฏิชีวนะ’ 
or 'yah pa ti chee wa na’) alongside ‘germ killer’ and specific 
antibiotic types like ‘corlam’ (chloramphenicol; 4.6%). In 
rural Salavan, a larger portion of 38.6% used the official 
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Figure 2 Common names and purposes for antibiotics. Source: Authors’ analysis of survey data. Notes: Only including 
respondents who indicated that they had seen the presented medicine (ie, common antibiotics) before. Chiang Rai: n=1076; 
Salavan: n=775. Population-weighted statistics, accounting for complex survey design. Multiple response permitted. Error bars 
indicate 95% CI.
term for antibiotics (‘ຢາຕ້ານເຊື້ອ’ or ‘yah dtan suea’, 
translated as ‘germ resister, but Salavan respondents were 
also more likely to use various colloquial expressions for 
specific types of antibiotics, like ‘Ampi’ with 75.6% and 
‘Amok’ with 35.3%.
Reported purposes of antibiotic use were yet more 
varied and are displayed in figure 2, Panel B. The 
overall most common use was the treatment of external 
wounds (Chiang Rai: 33.7%; Salavan: 44.4%; p<0.001). 
Other frequently reported uses in Salavan included 
coughs (30.5%; Chiang Rai: 10.9%; p<0.001) and fevers 
(30.5%; Chiang Rai: 8.3%; p<0.001). Thai respondents 
further indicated common use of antibiotics for sore 
throats (Chiang Rai: 36.3%, where it was the single most 
common use; Salavan: 28.9%; p=0.016) and for the more 
general idea of an ‘inflammation’ of the body (Chiang 
Rai: 23.5%; Salavan: 18.6%; p=0.083). Thai respondents 
would also more often limit their use to whatever a 
healthcare worker would recommend (Chiang Rai: 9.5%; 
Salavan: 5.4%; p=0.037), while 2.3% indicated that they 
would treat their plants or animals (dogs and chickens) 
with antibiotics (Salavan: 0.1%; p<0.001). Using antibi-
otics to treat infections or to fight bacteria and germs was 
only mentioned by a small minority of the rural popula-
tions (Chiang Rai: 2.4%; Salavan: 2.8%; p=0.243).
Table 1 indicates that—though people typically 
recognised the term ‘drug resistance’—the responses 
to the question ‘What do you think is drug resistance?’ only 
rarely corresponded to clinical definitions, and the coex-
istence of two common translations of the term in Lao 
PDR complicated the picture further. In Chiang Rai, 
10.6% of the interpretations related to antibiotics and/
or drug-resistant germs. Lao respondents linked the 
official term ‘due yah’ to clinical definitions in 7.7% of 
all interpretations, and the colloquial term ‘lueng yah’ in 
9.6% of all interpretations. Not unlike other high-income 
and low-income countries,28 drug resistance was typically 
interpreted as a growing tolerance of the body towards 
medicine as a result of repeated use (not limited to anti-
biotics). Other common interpretations in Chiang Rai 
were the incorrect or erratic use of medicine (12.5%), 
and an understanding of drug resistance as side effects 
of or allergic reactions to medicine in general (4.2%). 
In Salavan, ‘due yah’ was often interpreted as a refusal or 
‘stubbornness’ to take medicine (21.8%; possibly due to 
its literal translation into ‘stubborn (to the effect of) medi-
cine’), while its vernacular equivalent ‘lueng yah’ was often 
interpreted in the opposite way as a psychological depen-
dence or addiction to medicine (24.9%).
According to our survey data, 99.9% of the rural popu-
lation in Chiang Rai and 91.6% of the rural Salavan popu-
lation had a public primary healthcare centre within a 
10 km radius. Private sources were more varied, as 93.0% 
and 34% of the rural Chiang Rai population had a private 
clinic and a pharmacy within a 10 km radius, respectively 
(37.8% and 47.4% in Salavan, respectively), whereas 
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informal healthcare through shops and informal healers 
was nearly universally available within the survey villages 
(>97.8% in all cases).
Among our 2141 respondents, we captured 608 illness 
episodes in Chiang Rai and 356 in Salavan (see online 
supplementary appendix table 1). Healthcare utilisation 
during these episodes varied slightly across the two field 
sites. Chiang Rai respondents accessed a narrower spec-
trum of healthcare providers and were significantly less 
likely to access public and ‘other’ healthcare providers 
(p<0.001 in both cases). Both sites also exhibited a high 
level of medicine access, with 2.2 and 2.5 medicine use 
episodes during an illness in Chiang Rai and Salavan, 
respectively (p=0.050). Respondents in Chiang Rai thereby 
indicated higher use of non-antibiotic medicine (Chiang 
Rai: 1.6; Salavan: 1.3; p=0.048). In contrast, respondents 
in Salavan had more episodes of antibiotic use per illness 
(Chiang Rai: 0.2; Salavan: 0.4; p<0.001), and more usage 
of medicines that could potentially include antibiotics 
(Chiang Rai: 0.4; Salavan: 0.9; p<0.001). The pattern of 
antibiotic access was similar for informal sources, but 
generally lower in Chiang Rai: confirmed antibiotic use 
from informal channels represented 1.6% of all medi-
cine use episodes in Chiang Rai and 3.3% in Salavan; and 
3.6% in Chiang Rai and 7.9% in Salavan if unconfirmed 
but potential antibiotic use episodes are included.
Comparing the bivariate differences between indi-
viduals who accessed antibiotics from public, private 
and informal sources (see online supplementary file 1 - 
table A2) indicated that, contrary to intuition, patients 
receiving antibiotics from informal sources had no less 
wealth or formal education than users of public health-
care. Indeed, wealthier and more educated individuals 
in Chiang Rai were significantly associated with receiving 
antibiotics from informal sources (wealth: p=0.012; educa-
tion: p=0.032). Similarly, awareness of drug resistance was 
not significantly lower among patients who received anti-
biotics from informal sources, while the share of respon-
dents who linked drug resistance to biomedical notions 
of AMR in Salavan was significantly higher among indi-
viduals accessing antibiotics through informal channels 
compared with public channels (13.4% vs 4.4%, p=0.030). 
Patients who accessed antibiotics through informal chan-
nels were nevertheless significantly more inclined towards 
buying over-the-counter antibiotics than public antibiotic 
users (Chiang Rai: p=0.040; Salavan: p<0.001).
The results of the multivariate analysis are presented 
in table 2. The dependent variables were the number of 
confirmed antibiotic use episodes from public, private and 
informal sources; as a sensitivity check, we also included 
the more inclusive definition of ‘confirmed and poten-
tial’ antibiotic use episodes. The relationship between 
antibiotic-related knowledge and attitudes and antibiotic 
use was mixed. Among the most common knowledge-re-
lated and attitude-related predictors of antibiotic use was 
the respondents’ inclination to buy antibiotics. Again 
contrary to expectations, the attitude to not buy anti-
biotics over the counter was linked to disproportionate 
consumption of antibiotics from public sources. For 
example, patients who would not buy antibiotics over 
the counter would have 0.12 additional potential antibi-
otic use episodes in Chiang Rai (Model 7; 95% CI 0.01 
to 0.23) and up to 0.53 in Salavan (Model 8; 95% CI 
0.16 to 0.90), ceteris paribus. Also knowledge of antibi-
otics was positively associated with antibiotic consump-
tion from private sources in Chiang Rai (Model 3) and 
from public and informal sources in Salavan (Models 2 
and 6). In contrast, other antibiotic-related attitudes and 
knowledge linked negatively to antibiotic consumption. 
For example, the knowledge that antibiotic resistance can 
spread was linked to 0.25 fewer potential antibiotic use 
episodes from informal sources (Model 12, 95% CI −0.39 
to −0.10) and Chiang Rai patients who preferred alterna-
tives over antibiotics had 0.12 fewer confirmed antibiotic 
use episodes from private sources (Model 3; 95% CI −0.22 
to −0.03).
Among other covariates, wealthier patients had lower 
consumption of antibiotics from public (Chiang Rai 
and Salavan, Models 7 and 8) and higher consumption 
from private (Salavan, Model 4) and informal healthcare 
providers (Chiang Rai, Models 5 and 11)—presumably 
enabled by their higher purchasing power. Speakers of 
the majority language were also more likely to consume 
more antibiotics from public sources, which resonates 
with anecdotes encountered during the field research 
according to which speakers of minority languages tended 
to be less assertive in the patient-doctor encounter (the 
link to education was less clear). Not surprisingly, longer 
illness episodes were also associated with more antibiotic 
use episodes from public and private sources.
The Chow test indicated that the determinants of 
confirmed antibiotic use from private sources were signifi-
cantly different in Chiang Rai and Salavan (Models 3 and 
4; p=0.011), as were all sources of potential and confirmed 
antibiotic use (Models 7 to 12; p=0.056, p=0.015 and 
p=0.083 for public, private and informal antibiotic use, 
respectively).
DIsCussIOn AnD COnClusIOn
Our paper aimed at understanding AMR-related general 
population behaviour in LMICs through a description of 
antibiotic-related knowledge, attitudes and practices in 
rural Thailand and Lao PDR, and an assessment of the 
role of antibiotic-related knowledge and attitudes on anti-
biotic access from different types of healthcare providers. 
We demonstrated that rural populations exhibited:
 ► Mixed but surprisingly high levels of awareness and 
attitudes corresponding to AMR awareness-raising 
material, although only a minority of villagers were 
familiar with technical notions of antibiotics and drug 
resistance.
 ► Relatively low levels of antibiotic access from informal 
sources.
 ► Surprisingly counterintuitive links between informal 
antibiotic use, socioeconomic status, and their 
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attitudes—especially among villagers in Salavan, who 
had disproportionately high antibiotic use if their atti-
tude showed a disinclination against over-the-counter 
antibiotics.
Our survey data also revealed profound differences 
between the two field sites despite their cultural and 
geographical proximity. For example, villagers referred 
to antibiotics with wide-ranging and locally specific 
vernacular expressions (only a minority adopted tech-
nical language in either site), and ‘drug resistance’ was 
typically understood as a general tolerance of the body to 
medicine but local interpretations ranged from patients 
refusing medicine to patients being addicted to medi-
cine. Some of these differences could be explained by the 
local health system configuration. The better endowed 
and more regulated health system as well as the more 
extensive public health campaigns in Chiang Rai arguably 
contributed to the higher rates of public awareness and 
the comparatively lower rates of antibiotic use, whereas 
the Salavan health system faced more pressing trade-offs 
between ensuring access to and preventing the overuse 
of antibiotics. Alas, as the analysis has shown, antibi-
otic-related awareness and attitudes appeared to have 
little bearing on people’s antibiotic consumption when 
controlling for other determinants of medicine use.
The surveys were implemented after the monsoon 
season to reduce accessibility barriers like landslides, 
floods and farm work. This temporal focus meant that 
our survey was not able to capture internal migration or 
seasonal change affecting the epidemiological environ-
ment. The rural survey is also unable to speak for urban 
health behaviour or behavioural patterns outside rural 
Thailand and Lao PDR, or for awareness and behaviour 
among healthcare staff and policy makers (with which 
awareness-raising activities for the general public may 
interact). Lastly, our focus on health behaviour and our 
60-day recall period could introduce recall and social 
desirability biases. Most LMIC health behaviour research 
uses recall periods of 14–30 days; longer recall periods 
can lead to under-representation of lower educated 
groups.29 However, for a survey of behaviour rather than 
of epidemiological patterns, 14-day recall would have 
truncated the sample to an impractical size (omitting 
540/964 (56.0%) of all responses) and neglected that 
illness episodes often extended beyond a fortnight (as was 
the case for 91/964 (8.7%) of the recorded illnesses). In 
response, we conducted regular review sessions with our 
survey team to identify and alleviate social desirability; 
we excluded chronic illnesses; and our questionnaire 
asked our respondents to walk through the sequence of 
events, which improves recall.30 While we cannot rule out 
a residual risk of social desirability and recall bias, it is not 
clear a priori whether and how any remaining bias would 
affect our comparison of antibiotic uses across different 
healthcare providers.
By virtue of being a representative rural survey in 
northern Thailand and southern Lao PDR, the specific 
notions and behavioural patterns around antibiotic use 
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are not generalisable beyond the study context, although 
similar interpretations of antibiotics as ‘anti-inflamma-
tory medicine’ exist elsewhere (eg, in China),31 and even 
the documented practice of using antibiotics in plant 
cultivation has historical antecedents.32 Other study find-
ings like the widespread use of antibiotics for external 
(and often allegedly ‘internal’) wounds have few docu-
mented equivalents in other settings and deserve further 
research. However, the findings of our study have a 
broader relevance insofar as they expose the complexity 
of local knowledge and its relationship to AMR-related 
behaviour. On the one hand, our work underlines the 
challenges facing public awareness campaigns as the 
current principal strategy to change AMR-related popu-
lation behaviour. For example, if not mindful of the local 
context, the slogan of the 2017 World Antibiotic Aware-
ness Week to ‘use antibiotics wisely to combat rising drug 
resistance’ could plausibly entail increased antibiotic use or 
the use of stronger medicine if people understand drug 
resistance as stubbornness of patients or as a problem 
applying to all types of medicines.
On the other hand, our study also demonstrated that 
the link between knowledge, attitudes and antibiotic-re-
lated behaviour may be weak in LMIC contexts. This 
disjunction is not new,5 but the counterintuitive rela-
tionship between awareness, antibiotic-related attitudes 
and antibiotic use from informal sources suggests that 
AMR-related information can easily entail unintended 
consequences—knowledge and awareness empower, 
but people themselves decide how they will use this new 
‘power’ in their daily lives.33 For instance, villagers may 
not necessarily buy antibiotics from private clinics and 
unregulated corner shops because of ignorance, but 
because they become more assertive about their health 
(and increased wealth may enable patients to exercise 
this assertiveness).
Considering potential misunderstandings in AMR 
communication on the one hand and contextual deter-
minants of behaviour beyond knowledge deficits on the 
other, we call for an expansion of behavioural AMR strate-
gies to address structural factors of behavioural change. For 
example, vulnerability and adversity may drive people into 
seemingly irrational antimicrobial use.34 A sick labourer 
or factory worker may take antimicrobials desperately to 
maintain their job and to sustain their families, in which 
case it would be futile trying to convince them that their 
hardship is secondary to the global health goal of tackling 
AMR. Yet, it may be possible to alleviate their pressure 
to consume antimicrobials through paid sick leave and 
unemployment insurance. We propose the exploration of 
such ‘AMR-sensitive interventions’ to address upstream 
drivers of antimicrobial use and to complement education 
and awareness campaigns—similar to nutrition-sensitive 
interventions that target the determinants of malnutri-
tion and undernutrition through upstream interventions 
like social safety nets (rather than, eg, providing supple-
ments directly to people).35 AMR-sensitive interventions 
require us to venture out of health policy terrain into 
broader development policy. There is yet little evidence 
whether and how such context-oriented approaches bear 
fruit. Greater involvement of the social sciences is neces-
sary to uncover this gap and to find constructive solutions 
that address the social factors of which AMR is a symptom.
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